Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Varian
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
50.0%
+4.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:DominantThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Elekta
Competitor Displacement Rate
45.0%
Competitors are displacing Varian in 45.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Elekta's advancements in precision radiation therapy and integrated oncology software are leading to significant market share gains. Varian's ecosystem appears less cohesive.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[elekta.com][varian.com][accuro.com]⚠️ Identified Vulnerability:Oncology Solutions
Primary Threat Identified:Elekta
Target Persona:Radiation Oncologists
🚨 Threat Velocity:9/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)